FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$43.08 B | $43.65 B | $40.11 B | $41.95 B | $44.33 B | $45.13 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$19.86 B | $21.33 B | $20.07 B | $20.63 B | $19.72 B | $19.69 B |
Gross Profit Revenue minus cost of revenue. |
|
$23.21 B | $22.32 B | $20.04 B | $21.33 B | $24.61 B | $25.45 B |
|
Operating Expense
Costs to run business. 
|
|
$14.01 B | $13.96 B | $13.60 B | $14.47 B | $16.59 B | $17.27 B |
Operating Income Profit from operations. |
|
$9.20 B | $8.36 B | $6.44 B | $6.83 B | $8.05 B | $8.20 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$367.00 M | -$132.00 M | -$313.00 M | -$259.00 M | -$111.00 M | -$127.00 M |
Non-Operating Income (ex-Int) Income outside core operations. |
|
$579.00 M | -$259.00 M | -$927.00 M | -$765.00 M | -$538.00 M | -$612.00 M |
Total Other Income (Net) Net non-operating items. |
|
-$989.00 M | -$56.00 M | $229.00 M | $188.00 M | $418.00 M | -$65.00 M |
Income Before Tax Profit before taxes. |
|
$8.21 B | $8.31 B | $6.66 B | $7.01 B | $8.47 B | $8.14 B |
Income Tax Expense Taxes on income. |
|
$1.14 B | $1.37 B | $941.00 M | -$6.39 B | $1.94 B | $1.86 B |
|
Net Income
Final profit.
|
|
$7.07 B | $6.93 B | $5.72 B | $13.40 B | $6.52 B | $6.28 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$3.97 | $3.94 | $3.30 | $7.67 | $3.74 | $3.60 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$3.94 | $3.91 | $3.27 | $7.64 | $3.72 | $3.59 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
1.78 B | 1.75 B | 1.73 B | 1.73 B | 1.75 B | 1.75 B |
Diluted Average Shares Outst. Shares including dilution. |
|
1.79 B | 1.76 B | 1.75 B | 1.75 B | 1.75 B | 1.75 B |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$8.62 B | $8.62 B | $7.36 B | $7.62 B | $8.59 B | $8.81 B |
EBITDA Earnings before interest, tax, D&A. |
|
$12.16 B | $11.89 B | $10.61 B | $10.83 B | $11.33 B | $10.80 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$3.54 B | $3.27 B | $3.24 B | $3.22 B | $2.75 B | $1.99 B |
| Company Report |
FY 2025
Abbott Laboratories's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
Abbott Laboratories's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
Abbott Laboratories's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
Abbott Laboratories's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
